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ABSTRACT
Objective To perform genetic testing of patients with
congenital myasthenic syndromes (CMS) from the
Southern Brazilian state of Parana.
Patients and methods Twenty-five CMS patients from
18 independent families were included in the study.
Known CMS genes were sequenced and restriction
digest for the mutation RAPSN p.N88K was performed in
all patients.
Results We identified recessive mutations of CHRNE in
ten families, mutations in DOK7 in three families and
mutations in COLQ, CHRNA1 and CHRNB1 in one family
each. The mutation CHRNE c.70insG was found in six
families. We have repeatedly identified this mutation in
patients from Spain and Portugal and haplotype studies
indicate that CHRNE c.70insG derives from a common
ancestor.
Conclusions Recessive mutations in CHRNE are the
major cause of CMS in Southern Brazil with a common
mutation introduced by Hispanic settlers. The second
most common cause is mutations in DOK7. The
minimum prevalence of CMS in Parana is 0.18/100 000.
INTRODUCTION
Congenital myasthenic syndromes (CMS) are
a heterogeneous group of inherited disorders char-
acterised by impaired neuromuscular transmission.
Genes known to cause CMS if mutated are the
presynaptic choline acetyltransferase gene CHAT,
the gene COLQ encoding the triple-stranded colla-
genic tail (ColQ) of the synaptic acetylcholines-
terase, the genes encoding the different subunits of
the acetylcholine receptor (AChR) (CHRNA1,
CHRNB1, CHRND, CHRNE), the genes for the
postsynaptic proteins rapsyn (RAPSN), muscle-
specific kinase (MUSK) and MuSK-interacting
cytoplasmic protein Dok-7 (DOK7).1 Recently,
mutations in the gene encoding the laminin b2
subunit (LAMB2) have been shown to cause severe
CMS associated with congenital nephrosis and
ocular malformations.2
Here we present the molecular genetic findings of
25 CMS Brazilian patients. We found two novel
mutations in CHRNE and one novel mutation in
DOK7. The most frequently detected mutation
was CHRNE c.70insG which derives from
a common ancestor.
PATIENTS AND METHODS
Twenty-five CMS patients from 18 independent
families were included in the study. Pedigrees of five
CMS families are shown in online figure 1. All
patients were referred to a single center in Curitiba
and examined by two independent investigators.
Detailed neurological examination and electro-
physiological studies including 3-Hz repetitive
stimulation of proximal, distal and facial muscles
were performed.
Venous blood samples were obtained from the
patients as well as from their parents and siblings,
if available. In all CMS families screening for the
mutation RAPSN N88K was performed by restric-
tion digest. 100 healthy controls were screened for
each novel mutation.
Known CMS genes (CHRNE, DOK7, RAPSN,
COLQ, CHRNA1, CHRNB1, CHRND) were
sequenced depending on patients’ clinical
symptoms.
Haplotype studies using six polymorphic micro-
satellite markers on chromosome 17p13.2
(D17S1583, D17S1828, D17S1584, D17S1810,
D17S1832, D17S796) were performed in a total of
38 patients and family members carrying CHRNE
c.70insG and control individuals of Spanish or
Portuguese origin.
All the studies were carried out with informed
consent of the patients or parents and comply with
the ethical guidelines of the institutions involved.
RESULTS
We found the molecular defect causing CMS in
a total of 22 Brazilian patients. First we screened in
all families for the common mutations RAPSN p.
N88K and DOK7 c.1124_1127dupTGCC. Subse-
quently, we sequenced CHRNE in patients with
ophthalmoparesis and benefit from esterase inhibi-
tors. Sequencing of the exons encoding the extra-
cellular and transmembrane domains of AChR
subunits was performed in patients with slow-
channel CMS (SCCMS). Although the clinical
phenotype of patients 24 and 25 is compatible with
CMS, no mutations were found by sequencing
CHRNE, CHRNA1, CHRNB1, CHRND and RAPSN.
In patient 20 the common DOK7 mutation
c.1124_1127dupTGCC was found heterozygously.
A second DOK7 mutation was not identified on
genomic level. However, some DOK7mutations are
identifiable on cDNA only.3 No cDNA of our
patient was available for mutation analysis.
All patients presented with myasthenic symp-
toms at birth or in childhood. The individual clin-
ical data is summarised in table 1. Representative
photos of patients are shown in figure 1.
Molecular genetic analysis revealed recessive
mutations in CHRNE in a total of 16 patients out
< An additional figure is
published online only. To view
these files please visit the
journal online (http://jnnp.bmj.
com).
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of ten families, two of them are novel (table 1). The newly
identified mutation CHRNE p.L11P was detected homozygously
in patient 6 and leads to a substitution of a highly conserved
leucine. The mutation CHRNE p.S235L found in patient 11 has
not been previously reported, but was detected homozygously in
an Austrian CMS patient by us (unpublished data) and leads to
a substitution of a highly conserved serine. Interestingly, the
previously published mutation CHRNE c.70insG4 was found on
at least one allele in ten patients from six families. All of these
patients are of Portuguese or mixed Portuguese, European and
Indian origin (table 1).
Other previously published CHRNEmutations detected in our
patients are: CHRNE c.1293insG,5 found in four patients from
two families and CHRNE p.R286M6 detected homozygously in
two patients from two kinships.
Thus, mutations in CHRNE accounted for approximately 70%
of our Brazilian CMS patients with identified molecular defect.
The second most common molecular cause in this cohort is
DOK7 mutations, found in four patients (17%) from three
kinships (table 1). All of them carry the common mutation
DOK7 c.1124_1127dupTGCC heterozygously.
Two siblings are compound heterozygotes for a newly iden-
tified aminoacid exchange DOK7 p.G64R leading to a substitu-
tion of a highly conserved glycine.
Patient 17 carries the previously reported mutation DOK7
p.S45L7 together with the mutation DOK7
c.1124_1127dupTGCC.
Patient 21 (previously reported8) has a homozygous splice-site
mutation in COLQ.
Patients 22 and 23 with SCCMS carry previously reported
mutations heterozygously: CHRNB1 p.V266M9 and CHRNA1
p.G153S,10 respectively.
We and others have repeatedly identified patients from Spain
and Portugal harbouring the mutation CHRNE c.70insG.11
Haplotype studies of patients and family members carrying
CHRNE c.70insG showed that the distally adjacent polymorphic
microsatellite marker D17S1810 had a fragment length of 260bp
in 14 out of 18 70insG alleles (77.8%). In contrast, the same
fragment length (260bp) of D17S1810 was detected in 4 from 44
control alleles of Spanish or Portuguese descent only (9.1%). The
difference between controls and c.70insG carriers for marker
D17S1810 is statistically significant (p<0.01) providing genetic
evidence that the CHRNE c.70insG allele derives from
a common ancestor. We estimate that a single founder event for
the mutation CHRNE c.70insG may have occurred prior to the
immigration of Europeans to South America.
DISCUSSION
Here we present the molecular genetic findings of 25 Brazilian
CMS patients from the Southern Brazilian state of Parana.
Brazilians represent one of the most heterogeneous popula-
tions in the world reflecting the admixture of Europeans,
Amerindians, Africans and Asians with regional differences of
European, Amerindian and African matrilineal genetic contri-
bution to the Brazilian mtDNA pool.12
We found that CHRNE mutations are the most common
cause of CMS in Southern Brazil with CHRNE c.70insG muta-
tion being the most frequently detected. Haplotype analysis of
CHRNE c.70insG families suggests that this is an old founder
mutation and the founder allele is shared by patients from Spain
and Portugal. Similarly, CHRNE p.R286M has been previously
identified in four patients from two Portuguese families from our
CMS cohort (unpublished observation) and CHRNE c.1293insGTa
bl
e
1
C
on
tin
ue
d
P
at
ie
nt
nu
m
be
r
Fa
m
ily
nu
m
be
r
S
ex
,
ag
e
Et
hn
ic
or
ig
in
C
on
sa
n
gu
in
eo
us
fa
m
ily
A
ge
of
on
se
t
(y
ea
rs
)
D
el
ay
ed
m
ot
or
m
ile
s
to
ne
s
R
es
pi
ra
to
ry
cr
is
es
P
to
si
s/
op
ht
ha
l
m
op
ar
es
is
/
fa
ci
al
w
ea
kn
es
s/
dy
sp
ha
gi
a
P
ro
xi
m
al
w
ea
kn
es
s/
w
ad
dl
in
g
ga
it
/
sc
ap
ul
ar
w
in
gi
ng
/
at
ro
ph
ie
s
D
is
ta
l
m
us
cl
e
w
ea
kn
es
s/
se
le
ct
iv
e
in
vo
lv
em
en
t
of
w
ri
st
an
d
fin
ge
r
ex
te
ns
or
s
A
xi
al
/n
ec
k
m
us
cl
es
w
ea
kn
es
s/
sc
ol
io
si
s
or ky
ph
os
is
A
bn
or
m
al
te
nd
on
re
fle
xe
s
P
ro
gr
es
si
ve
di
se
as
e
co
ur
se
El
ec
tr
op
hy
si
ol
og
ic
al
st
ud
ie
s
R
N
S
de
cr
em
en
t
D
ou
bl
e
C
M
A
P
M
yo
pa
th
ic
po
te
nt
ia
ls
B
en
efi
ci
al
re
sp
on
se
to
ac
et
yl
ch
o-
lin
es
te
ra
se
in
hi
bi
to
rs
G
en
e/
M
ut
at
io
ns
21
14
M 19
In
di
an
A
fr
ic
an
+
<
1
+

+
/+
/+
/
+
/+
/+
/+
+
/
+
/
/+
+
+
+
+
+
+
*
C
O
LQ
IV
S
2+
1G
>
C
/
IV
S
2
+
1G
>
C
22
15
M 28
Po
rt
ug
ue
se
Le
ba
ne
se

B
irt
h


+
/+
/
/+
+
/
/+
/+
/

+
/
/+

+
+
+
+
y
C
H
R
N
B
1
V
26
6M
23
16
F 13
S
pa
ni
sh
Ita
lia
n

1
+

/
/
/

+
/+
/+
/+
+
/
/
/

+
+
+
+
+
y
C
H
R
N
A
1
G
15
3S
24
17
F 5
nd

2


+
/+
/
/
/
/
/

/

/
/



+

nd

no
id
en
tifi
ed
m
ol
ec
ul
ar
de
fe
ct
25
18
F 9
nd

3


+
/+
/
/
/
/
/

/

/
/



+

nd
+
no
id
en
tifi
ed
m
ol
ec
ul
ar
de
fe
ct
Th
e
ne
w
ly
id
en
tifi
ed
m
ut
at
io
ns
ar
e
in
bo
ld
an
d
un
de
rli
ne
d.
+
in
di
ca
te
s
ye
s;
,
no
;
nd
,
no
da
ta
;
nt
,
no
t
tr
ie
d.
*A
lth
ou
gh
th
e
pa
tie
nt
re
po
rt
ed
su
st
ai
ne
d
be
ne
fit
,
th
er
e
is
la
ck
of
ob
je
ct
iv
e
cl
in
ic
al
im
pr
ov
em
en
t.
yB
en
efi
t
fr
om
tr
ea
tm
en
t
w
ith
flu
ox
et
in
e.
J Neurol Neurosurg Psychiatry 2010;81:973e977. doi:10.1136/jnnp.2009.177816 975
Short report
 group.bmj.com on January 19, 2014 - Published by jnnp.bmj.comDownloaded from 
mutation has been reported causing CMS in patients of North-
African, Portuguese and Spanish origin.11
CHRNE mutations are the most common cause of CMS in
patients from Portugal analysed in our laboratory (a total of 11
Portuguese patients with identified molecular defect) accounting
for 72.7% of the patients, that is, nearly the same frequency that
we observed in our Brazilian cohort. The second most common
cause is DOK7mutations. In contrast, approximately half of our
German CMS patients (a total of 42 German patients with
identified molecular defect) have mutations in RAPSN while
mutations in CHRNE are found in 17% of the patients
(unpublished results).
Taken together these findings indicate a strong influence of
the Portuguese ancestry on the people from Parana which is in
line with the data from mtDNA studies showing major Euro-
pean matrilineal genetic contribution to the mtDNA pool in
Southern Brazil.12
The second molecular cause of CMS in Parana according to
frequency is DOK7 mutations. We found the common mutation
DOK7 c.1124_1127dupTGCC in four patients. The mutation
DOK7 p.S45L has previously been identified by us in one
Portuguese patient and another patient from South America.7
The novel mutation DOK7 p.G64R has not previously been
observed in any European CMS patient. The two siblings who
carry it derive from a non-consanguineous family of mixed
Portuguese, Amerindian and African descent. It can be specu-
lated that DOK7 p.G64R is specific for the indigenous Amerin-
dians or Africans, so testing of CMS patients from Northern and
Northeastern Brazil is of particular interest as the Amerindian
and African matrilineal genetic contribution to the mtDNA pool
in these regions is greater than in the Southern Brazil.12
We did not detect the common European RAPSN p.N88K
mutation1 in the Brazilian CMS cohort. The likely reason for
this is underdiagnosis of CMS among hospitalised neonates at
Intensive Care Units and the benign course of the disease in
RAPSN patients with lack of progression with age. Alternatively,
this mutation could be very rare in Brazil, similarly to patients
from Portugal (RAPSN N88K was detected heterozygously in
one patient out of 11 of our CMS Portuguese patients).
The Southern Brazilian state of Parana has a total population
of 10 million inhabitants. Eighteen independent CMS families
included in the study were referred to a single neuromuscular
center in Curitiba. Based on these figures, the estimated
minimum prevalence of CMS in Parana is approximately 0.18 in
100 000, which does not differ from figures published for Europe
prior to the identification of DOK7 mutations.13 The prevalence
Figure 1 Photos of CMS patients A. Patient 12. The patient has ptosis and ophthalmoparesis. B. Patients 13 and 14 show scapulae alatae. C, D.
Patient 19. Note pronounced lordosis and scoliosis. E, F. Patient 17. Note proximal weakness, pronounced lordosis and scapulae alatae. G, H, I. Patient
23. She has no involvement of the ocular muscles. Note pronounced lordosis and scapulae alatae. J, K. Patient 18. She has ptosis and facial weakness.
Note severe scoliosis.
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may be underestimated assuming that there are underdiagnosed
patients that have not been referred to Curitiba.
With our findings we show that molecular epidemiology of
CMS in Parana - similar to other disorders (eg, spinocerebellar
ataxia)dreflects the major Portuguese ancestry of the Brazilian
population. Recessive mutations in CHRNE are the most
common cause of CMS in Southern Brazil with a common
founder mutation introduced by Hispanic settlers. In practical
terms, we recommend to start genetic testing for CMS in Brazil
with screening for mutations in CHRNE followed by DOK7.
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